Unlike other approved GLP-1 medications, Wegovy and Zepbound, which also target the gut hormone GLP-1, retatrutide targets three receptors known to regulate appetiteGLP-1, glucagon and glucose-dependent insulinotropic polypeptide (GIP)
Lilly reported sales of $8.7 billion for Mounjaro in the first quarter and $4.2 billion for Zepbound, for a combined $12.9 billion
Nasca's animal studies suggest that acetyl-L-carnitine, a crucial mediator of fat metabolism and energy production throughout the body, plays a special role in the brain, where it works at least in part by preventing the excessive firing of excitatory nerve cells in brain regions called the hippocampus and frontal cortex
Okuma A, Hoshino K, Ohba T, Fukushi S, Aiba S, Akira S, et al
Birth defects surveillance after assisted reproductive technology in Beijing: a whole of population-based cohort study